| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael E. Prevoznik | SVP General Counsel | 2026-03-05 | 3,878 | $206.21 | $799.68kSell |
| Catherine T. Doherty | EVP Regional Businesses | 2026-03-05 | 5,558 | $206.21 | $1.15MSell |
| Patrick Plewman | SVP for Diagnostic Services | 2026-03-05 | 2,855 | $206.21 | $588.73kSell |
| Sam Samad | Executive Vice President CFO | 2026-03-04 | 13,947 | $204.86 | $2.86MBuy |
| Michael E. Prevoznik | SVP General Counsel | 2026-03-04 | 3,354 | $204.86 | $687.10kSell |
| Michael E. Prevoznik | SVP General Counsel | 2026-03-04 | 7,232 | $204.86 | $1.48MBuy |
| Patrick Plewman | SVP for Diagnostic Services | 2026-03-04 | 2,827 | $204.86 | $579.14kSell |
| Patrick Plewman | SVP for Diagnostic Services | 2026-03-04 | 5,682 | $204.86 | $1.16MBuy |
| Karthik Kuppusamy | SVP Clinical Solutions | 2026-03-04 | 2,628 | $204.86 | $538.37kSell |
| J. E. Davis | CEO and President | 2026-03-04 | 51,652 | $204.86 | $10.58MBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 13.10% | 14,392,082 | $2.87B | Institution |
| Blackrock Inc | 8.61% | 9,459,218 | $1.88B | Institution |
| Price T Rowe Associates Inc | 5.73% | 6,297,157 | $1.25B | Institution |
| State Street Corp | 4.90% | 5,382,547 | $1.07B | Institution |
| Jpmorgan Chase Co | 3.77% | 4,145,896 | $825.90M | Institution |
| Boston Partners | 3.56% | 3,913,326 | $779.57M | Institution |
| Geode Capital Management LLC | 2.76% | 3,028,207 | $603.25M | Institution |
| Morgan Stanley | 2.45% | 2,693,568 | $536.59M | Institution |
| Victory Capital Management Inc | 1.94% | 2,126,422 | $423.60M | Institution |
| Dimensional Fund Advisors LP | 1.76% | 1,931,548 | $384.78M | Institution |